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Abstract
Background: Aplasia cutis congenita is a disorder where e newborn child is missing skin from
certain areas. It is a rare condition with no particular race or sex more at risk. May occur by itself
or be associated with other physical syndromes or disorders. A classification system exists for
aplasia cutis congenital consisting of 9 groups, based on the number and location of the skin defects
and the presence or absence of other malformations. Causes of aplasia congenital could be
heredity, teratogenic substances, placental infarcts, intrauterine infections, ectodermal dysplasias
etc. Diagnosis is made based on the clinical findings. Prognosis depends of the other organs
malfunction level and lesions size.
Case report: Our case was an 22 months old Albanian girl, who was recommended to
dermatology for a consultation by a pediatric surgeon because of the changes she had on her
parietal part of the scalp with missing hair areas. The child has stenosis congenita ani and to her
was installed stoma. In order to investigate other accompanied anomalies of the disease, there are
made specific consults by neurologist, orthopedist, cardiologist, nephrologists and citogenetics.
Conclusion: It was found out a minor visual discoordination, Sy Floppy, Digiti V superductus pedis
bill. Laxitas articularum generalisata.
It was a great challenge for us to find out that during the first trimester of the pregnancy (unplanned
pregnancy), her mother used Diclofenac.
Since there is limited information regarding to teratogenic effects of diclofenac, we considered it 
interesting to present this case.
Introduction
Aplasia cutis congenita is one of the disorders of the skin
embrional development. It is characterized by a limited
defect of the skin where the skin layers and its adnexes are
not created. This feature is rare, about 1 in 3000 alive born
children [1-3].
Except sporadic cases, there are familiar cases, which are
explained by autosomal -dominant heredity [4]. Causes of
aplasia could be teratogenic substances, placental infarcts,
intrauterine infections, ectodermal displasias etc [5,6].
The disorders during the skin development can include
one or all skin layers. Sometimes the other deep structures
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like fascia, ossa and dura are missing (which can be fol-
lowed by different cosmetic defects of the skin until the
deformities incompatible with life). Aplasia cutis congen-
ita is manifested by the defects of the skin mostly oval, 1-
3 cm in diameter, with localization on the parietal part of
scalp (60%) and rarely on the face and extremities. It
belongs to the group of congenital cicatricial alopecia.
Aplasia cutis congenita can be associated by a lot of anom-
alies as: labium leporinum, polycystic kidneys, psycho-
motor retardation, developing disorders of the eyes,
spinal cord, ears, chromosomal aberationes, cutis mar-
morata, congenital organoid nevus on the scalp and face,
anomalies on extremities, intestines and genital organs.
Based on the presence of these anomalies and their asso-
ciation with the other diseases as bullous epidermolysis,
growth and development stagnation, etc, congenital apla-
sias of the skin are classified in 9 groups.
Diagnosis is made based on the clinical findings, and the
histopathology is not necessary.
Prognosis depends of the other organs malfunction level
and lesions size.
The lesions can resolve spontaneously, but sometimes is
needed surgery operation (punch-graft-transplant).
Case presentation
Patient aged 22 months, Albanian female, hospitalized in
Clinic, by pediatric surgeon recommendation, because of
the changes on the scalp with missing hair areas. This
alteration persists from the birth without tendency for
shape changing.
On the parietal part of the scalp appear two oval shaped
areas without hair, confluated, with light depth and
shinny bases (Figure 1).
Her mother mentioned that during the first trimester of
the pregnancy (she did not know that she was pregnant)
has taken Diclofenac amp. (five days) because she had
abdominal pains. During pregnancy she did not have any
infectious disease. Family history is negative.
In the surgery clinic the child was operated and treated
under the diagnoses: Stenosis congenita ani and was
installed stoma (Figure. 2). For associated defects in other
organs, there are made specific consults.
Consultant orthopedist concluded the digiti V superduc-
tus pedis bilateralis, laxitas articularum generalisata and
Sy Floppy (Figure 3a and Figure 3b).Consultant neurolo-
gist indicated minor visualmotor discoordination. Cardi-
ologists and nephrolog consulting resulted on the
common stage. Citogenetic report has shown Cariotype
46, XX with no changes on the chromosome number and
structure.
The routine laboratory examinations resulted with com-
mon values except the blood SE rate, which was increased
(60/1 h). After the antibiotic ordination (Cephalexin sir.
A 125 mg), the same fall down to 15/1 h. The patient was
discharged home with recommendation to follow up the
pediatric surgeon visits.
Conclusion
Aplasia cutis congenita is very rare anomaly (1:3000).
Causes of congenital aplasia could be teratogenic sub-
The parietal part of the scalp appear two oval shaped areas  without hair, confluated, with light depth and shinny bases Figure 1
The parietal part of the scalp appear two oval shaped 
areas without hair, confluated, with light depth and 
shinny bases.
Installed stoma (anus praeternaturalis) Figure 2
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stances [7]. Diclofenac is a non-steroidal anti-inflamma-
tory drug (NSAID), commonly used by reproductive age
women for the treatment of variety of conditions. NSAID
inhibit the biosynthesis of prostanoids. Women may inci-
dentally become pregnant while receiving NSAID therapy
(unplanned pregnancy) [8]. The diclofenac crosses the
placenta readily in the first trimester of human pregnancy
resulting in a fetal diclofenac concentration. which is the
same as the maternal serum concentration [9]. The drug
may also accumulate in fetal tissue with time [9]. Usually
diclofenac is given in multiple doses, so the possibility to
reach teratogenic levels of fetal tissue concentrations is
real in patients who are taking diclofenac. In our case the
pregnant women received diclofenac 75 mg per day, five
days. Diclofenac has also been shown to inhibit implan-
tation and embryogenic development in rats when given
on gestation day 5 [10]. A positive association between
use of NSAID during pregnancy and miscarriages was
reported by a study [11]. However, information regarding
teratogenecity of NSAID during the critical period of org-
anogenesis is lacking. Because aspirin and other NSAID
share a similar mechanism of action (inhibition of pros-
taglandin synthesis) it was postulated that NSAID might
induce congenital abnormalities when given during the
critical period of organogenesis [12].
We present patient with aplasia cutis congenita accompa-
nied by stenosis congenita ani, digiti V superductus pedis
bill., laxitas articularum generalisata-sy Floppy and minor
visualmotor discoordination. Based on mentioned stud-
ies and real clinical situation we concluded that
Diclofenac used in early trimester of pregnancy might
induce those abnormalities and considered reasonable to
present this case.
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